MRNA Stockholders Equity

Moderna · Stockholders Equity

MRNA logo

MRNA Stockholders Equity

Latest reported$8.65B
MRNA FY Shareholders Equity ($841.85M → $8.65B)
High-resolution chart · PNG

MRNA stockholders equity history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Stockholders Equity — Annual fiscal periods (USD)
Period endingStockholders Equity (USD)
8,650,000,000
10,901,000,000
13,854,000,000
19,123,000,000
14,145,000,000
2,561,000,000
1,174,810,000
1,530,241,000
625,296,000
841,851,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.